Logo image
Zirconium tetraazamacrocycle complexes display extraordinary stability and provide a new strategy for zirconium-89-based radiopharmaceutical development
Journal article   Open access   Peer reviewed

Zirconium tetraazamacrocycle complexes display extraordinary stability and provide a new strategy for zirconium-89-based radiopharmaceutical development

Darpan N Pandya, Nikunj Bhatt, Hong Yuan, Cynthia S Day, Brandie M Ehrmann, Marcus Wright, Ulrich Bierbach and Thaddeus J Wadas
Chemical science (Cambridge), Vol.8(3), pp.2309-2314
03/01/2017
DOI: 10.1039/c6sc04128k
PMCID: PMC5363373
PMID: 28451334
url
https://doi.org/10.1039/c6sc04128kView
Published (Version of record) Open Access

Abstract

We report our initial investigations into the use of tetraazamacrocycles as zirconium-89 chelators. We describe the synthesis and complete characterization of several Zr tetraazamacrocycle complexes, and definitively describe the first crystal structure of zirconium 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (Zr-DOTA) using single crystal X-ray diffraction analysis. After evaluating several radioactive analogs, we found that Zr-DOTA is superior to Zr-DFO, the only Zr-complex to be used clinically in Zr-radiopharmaceutical applications. Finally, we provide a rationale for the unanticipated and extraordinary stability of these complexes and . These results may inform the development of safer and more robust immuno-PET agents for precision medicine applications.

Details

Logo image